TAK logo

TAK

Profile

Full Name

Takeda Pharmaceutical Company Limited

Ticker Symbol

TAK

Exchange

NYSE

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

Japan

IPO

January 5, 2010

Indexes

Not included

Website

http://www.takeda.com

Employees

49281

Key Details

Price

$14.30(+3.03%)

Market cap

Last Dividend

$0.33

TTM Dividend yield

2.28%

Annual revenue

$29.55B(-0.93% YoY)

Annual EPS

$0.32(-57.75% YoY)

PE ratio

33.59

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$14.30
TAK price is $14.30

30-Day Relative Volume

0.86
TAK 30-day relative volume is 0.86

Price Performance

Price Most recent change

+3.03%
TAK price was up +3.03% on Apr 14, 2025

Price YTD change

+8.01%
TAK price is up +8.01% since January 1st

Price 1-year change

+8.5%
TAK price is up +8.5% year-on-year

Price 3-year change

-4.09%
TAK price is down -4.09% over the past 3 years

Price Range

Price All-time high

$31.29
TAK price is currently -54.30% below its historical high of $31.29

Price 3-year low

$12.28
TAK price is currently +16.45% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$45.34B
TAK market capitalization is $45.34 billion

Market cap 3-year change

-2.52%
TAK market capitalization is down -2.52% over the past 3 years

Market cap All-time high

$66.78B
TAK market capitalization is currently -32.11% below its historical high of $66.78 billion

Market cap sector rank

97.45%
TAK market capitalization is higher than 97.45% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+1.03%
TAK shares outstanding is up +1.03% year-on-year

Shares Outstanding 3-Year Change

+1.64%
TAK shares outstanding is up +1.64% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.22
TAK beta is 0.22

200-day SMA

$13.99
TAK price is currently +2.21% above its 200-day simple moving average

50-day SMA

$14.44
TAK price is currently -0.95% below its 50-day simple moving average

RSI

44.61
TAK 14-day relative strength index is 44.61

Volume

0.86
TAK 30-day relative volume is 0.86

ATR

$0.36
TAK average true range is $0.36

10-day Historical Volatility

35.38%
TAK 10-day historical volatility is 35.38%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.33
TAK last dividend was $0.33 per share, with an ex-dividend date of September 30, 2024

Next Dividend

-
TAK next dividend has not yet been announced

Dividend per share

Dividend per share

$0.61
TAK annual dividend per share is $0.61

Dividend per share Sector Rank

24.42%
TAK annual dividend per share is higher than 24.42% of companies in Healthcare sector

Dividend per share 1-Year Change

-4.42%
TAK annual dividend per share is down -4.42% year-on-year

Dividend per share 3-Year Change

-26.97%
TAK annual dividend per share is down -26.97% over the past 3 years

Dividend yield

Dividend yield

4.27%
TAK annual dividend yield is 4.27%

Dividend yield Sector Rank

76.47%
TAK annual dividend yield is higher than 76.47% of companies in Healthcare sector

Other

Payout ratio

199.34%
TAK annual payout ratio is 199.34%

Dividends paid

$1.99B
TAK annual dividends paid is $1.99 billion

Free cash flow

$1.63B
TAK annual free cash flow is $1.63 billion

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$29.55B
TAK annual revenue is $29.55 billion

Revenue Analysts estimate

$4613.19B
TAK annual revenue is currently -99.36% lower than the consensus analysts' forecast

Revenue 1-year change

-0.93%
TAK annual revenue is down -0.93% year-on-year

Revenue Sector rank

96.98%
TAK annual revenue is higher than 96.98% of companies in Healthcare sector

EPS

EPS

$0.32
TAK annual earnings per share is $0.32

EPS Analysts estimate

-
TAK annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

-57.75%
TAK annual earnings per share is down -57.75% year-on-year

EPS Sector rank

85.94%
TAK annual earnings per share is higher than 85.94% of companies in Healthcare sector

Profit

Gross profit

$19.66B
TAK annual gross profit is $19.66 billion

Gross margin

66.54%
TAK annual gross profit margin is 66.54%

Operating profit

$1.48B
TAK annual operating income is $1.48 billion

Operating margin

5.02%
TAK annual operating profit margin is 5.02%

Net income

$998.37M
TAK annual net profit is $998.37 million

Net margin

3.38%
TAK annual net profit margin is 3.38%

Expenses

Total expenses

$28.06B
TAK annual total expenses is $28.06 billion

Operating expenses

$18.18B
TAK annual total operating expenses is $18.18 billion

Cost of goods sold

$9.89B
TAK annual cost of goods sold is $9.89 billion

Selling, general & administrative expenses

$7.30B
TAK annual SGA is $7.30 billion

Depreciation and amortization

$5.04B
TAK annual depreciation & amortization is $5.04 billion

Interest expense

$1.52B
TAK annual interest expense is $1.52 billion

Income tax

-$633.43M
TAK annual income tax is -$633.43 million

EBIT & EBITDA

EBIT

$1.89B
TAK annual earnings before interest & taxes is $1.89 billion

EBITDA

$6.93B
TAK annual EBITDA is $6.93 billion

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$99.82B
TAK annual total assets is $99.82 billion

Non current assets

$82.92B
TAK annual long term assets is $82.92 billion

Current assets

$16.90B
TAK annual total current assets is $16.90 billion

Cash and cash equivalents

$3.02B
TAK annual cash & cash equivalents is $3.02 billion

Accounts receivable

$4.75B
TAK annual accounts receivable is $4.75 billion

Inventory

$7.99B
TAK annual inventory is $7.99 billion

Liabilities

Total liabilities

$51.76B
TAK annual total liabilities is $51.76 billion

Long term liabilities

$36.48B
TAK annual total long term liabilities is $36.48 billion

Current liabilities

$15.28B
TAK annual total current liabilities is $15.28 billion

Accounts payable

$2.11B
TAK annual accounts payable is $2.11 billion

Debt

Total debt

$32.00B
TAK annual total debt is $32.00 billion

Total debt 1-year change

-2.7%
TAK annual total debt is down -2.7% year-on-year

Long term debt

$29.58B
TAK annual long term debt is $29.58 billion

Short term debt

$2.43B
TAK annual short term debt is $2.43 billion

Equity & Capital

Shareholders equity

$48.05B
TAK annual stockholders equity is $48.05 billion

Book value

$48.05B
TAK annual book value is $48.05 billion

Retained earnings

$9.19B
TAK annual retained earnings is $9.19 billion

Working capital

$1.62B
TAK annual working capital is $1.62 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$4.96B
TAK annual cash flow from operations is $4.96 billion

Cash from operations 1-year change

-31.4%
TAK annual cash flow from operations is down -31.4% year-on-year

Cash from investing

-$3.21B
TAK annual cash flow from investing activities is -$3.21 billion

Cash from investing 1-year change

+28.5%
TAK annual cash flow from investing activities is up +28.5% year-on-year

Cash from financing

-$2.46B
TAK annual cash flow from financing activities is -$2.46 billion

Cash from financing 1-year change

+53.23%
TAK annual cash flow from financing activities is up +53.23% year-on-year

CAPEX

CAPEX

$3.33B
TAK annual capital expenditures is $3.33 billion

CAPEX 1-year change

-29.01%
TAK annual capital expenditures is down -29.01% year-on-year

Free Cash Flow

Free cash flow

$1.63B
TAK annual free cash flow is $1.63 billion

Free cash flow 1-year change

-35.81%
TAK annual free cash flow is down -35.81% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

66.54%
TAK annual gross profit margin is 66.54%

Operating margin

5.02%
TAK annual operating profit margin is 5.02%

Net margin

3.38%
TAK annual net profit margin is 3.38%

ROA & ROE

ROA

0.98%
TAK annual return on assets is 0.98%

ROE

2.09%
TAK annual return on equity is 2.09%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

33.59
TAK price to earnings ratio is 33.59

PE ratio Sector rank

65.2%
TAK price to earnings ratio is higher than 65.2% of companies in Healthcare sector

PB Ratio

PB ratio

0.96
TAK price to book ratio is 0.96

PB ratio Sector rank

43.46%
TAK price to book ratio is higher than 43.46% of companies in Healthcare sector

PS Ratio

PS ratio

1.50
TAK price to sales ratio is 1.50

PS ratio Sector rank

35.77%
TAK price to sales ratio is higher than 35.77% of companies in Healthcare sector

Enterprise value

Enterprise value

$73.01B
TAK enterprise value is $73.01 billion

Enterprise value Sector rank

97.77%
TAK enterprise value is higher than 97.77% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

10.09
TAK EV/EBITDA is 10.09

EV/EBITDA Sector rank

82.61%
TAK EV/EBITDA is higher than 82.61% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.11
TAK annual current ratio is 1.11

Quick ratio

0.58
TAK annual quick ratio is 0.58

Leverage

Debt to equity

0.67
TAK annual debt to equity ratio is 0.67

Interest coverage ratio

1.24
TAK annual interest coverage ratio is 1.24

Risk & Stability

Piotroski F-Score

7
TAK piotroski f-score is 7

Altman Z-Score

1.03
TAK altman z-score is 1.03

Analyst ratings

Recent major analysts updates

May 16, 23 TD Cowen
Outperform
Apr 4, 23 TD Cowen
Outperform
Mar 16, 23 B of A Securities
Buy
Jul 19, 22 Cowen & Co.
Outperform
Oct 7, 21 Morgan Stanley
Equal-Weight
Mar 11, 20 JP Morgan
Overweight
Nov 1, 19 Cowen & Co.
Market Perform
Sep 24, 19 Jefferies
Buy

Institutional Ownership

Similar stocks

HLN logo
Haleon (HLN)
ALC logo
Alcon (ALC)
EW logo
Edwards Lifesciences (EW)
ARGX logo
argenx SE (ARGX)
VEEV logo
Veeva Systems (VEEV)
HUM logo
Humana (HUM)
IDXX logo
IDEXX Laboratories (IDXX)
CAH logo
Cardinal Health (CAH)
BDX logo
Becton Dickinson and Company (BDX)
  • What is the ticker symbol for Takeda Pharmaceutical Company Limited?
  • Does Takeda Pharmaceutical Company Limited pay dividends?
  • What sector is Takeda Pharmaceutical Company Limited in?
  • What industry is Takeda Pharmaceutical Company Limited in?
  • What country is Takeda Pharmaceutical Company Limited based in?
  • When did Takeda Pharmaceutical Company Limited go public?
  • Is Takeda Pharmaceutical Company Limited in the S&P 500?
  • Is Takeda Pharmaceutical Company Limited in the NASDAQ 100?
  • Is Takeda Pharmaceutical Company Limited in the Dow Jones?
  • When was Takeda Pharmaceutical Company Limited's last earnings report?
  • When does Takeda Pharmaceutical Company Limited report earnings?

What is the ticker symbol for Takeda Pharmaceutical Company Limited?

The ticker symbol for Takeda Pharmaceutical Company Limited is NYSE:TAK

Does Takeda Pharmaceutical Company Limited pay dividends?

Yes, Takeda Pharmaceutical Company Limited pays dividends. The last payment was $0.33, with an ex-dividend date on September 30, 2024

What sector is Takeda Pharmaceutical Company Limited in?

Takeda Pharmaceutical Company Limited is in the Healthcare sector

What industry is Takeda Pharmaceutical Company Limited in?

Takeda Pharmaceutical Company Limited is in the Drug Manufacturers - Specialty & Generic industry

What country is Takeda Pharmaceutical Company Limited based in?

Takeda Pharmaceutical Company Limited is headquartered in Japan

When did Takeda Pharmaceutical Company Limited go public?

Takeda Pharmaceutical Company Limited's initial public offering (IPO) was on January 5, 2010

Is Takeda Pharmaceutical Company Limited in the S&P 500?

No, Takeda Pharmaceutical Company Limited is not included in the S&P 500 index

Is Takeda Pharmaceutical Company Limited in the NASDAQ 100?

No, Takeda Pharmaceutical Company Limited is not included in the NASDAQ 100 index

Is Takeda Pharmaceutical Company Limited in the Dow Jones?

No, Takeda Pharmaceutical Company Limited is not included in the Dow Jones index

When was Takeda Pharmaceutical Company Limited's last earnings report?

Takeda Pharmaceutical Company Limited's most recent earnings report was on Jan 30, 2025

When does Takeda Pharmaceutical Company Limited report earnings?

The next expected earnings date for Takeda Pharmaceutical Company Limited is May 9, 2025
On this page